Related Experiment Video
Updated: Feb 4, 2026

A Mouse Model for Laser-induced Choroidal Neovascularization
Published on: December 27, 2015
Inhibition of Experimental Choroidal Neovascularization by a Novel Peptide Derived from Calreticulin Anti-Angiogenic
Youn-Shen Bee1,2,3, Yi-Ling Ma4, Jinying Chen5,6
1Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan. ysbee@vghks.gov.tw.
Abstract:
Choroidal neovascularization (CNV) is a key pathological feature of several leading causes of vision loss including neovascular age-related macular degeneration. Here, we show that a calreticulin anti-angiogenic domain (CAD)-like peptide 27, CAD27, inhibited in vitro angiogenic activities, including tube formation, migration of endothelial cells, and vascular sprouting from rat aortic ring explants. In a rat model of laser-induced CNV, we demonstrate that intravitreal injection of CAD27 significantly attenuated the formation of CNV lesions as measured via fundus fluorescein angiography and choroid flat-mounts (19.5% and 22.4% reductions at 10 μg and 20 μg of CAD27 injected, respectively). Similarly, the reduction of CNV lesions was observed in rats that had received topical applications of CAD27 (choroid flat-mounts: 17.9% and 32.5% reductions at 10 μg/mL and 20 μg/mL of CAD27 instilled, respectively). Retinal function was unaffected, as measured using electroretinography in both groups receiving interareal injection or topical applications of CAD27 for at least fourteen days. These findings show that CAD27 can be used as a potential therapeutic alternative for targeting CNV in diseases such as neovascular age-related macular degeneration.
Insights
A novel peptide, CAD27, effectively reduced choroidal neovascularization (CNV) in preclinical models. This peptide shows promise as a therapeutic for vision-threatening conditions like age-related macular degeneration.
Area of Science:
- Ophthalmology
- Angiogenesis Research
- Drug Discovery
Background:
- Choroidal neovascularization (CNV) is a critical factor in vision loss, notably in neovascular age-related macular degeneration.
- Current treatments for CNV have limitations, necessitating novel therapeutic strategies.
Purpose of the Study:
- To evaluate the anti-angiogenic potential of a calreticulin anti-angiogenic domain (CAD)-like peptide 27 (CAD27).
- To assess CAD27's efficacy in inhibiting choroidal neovascularization in a preclinical rat model.
Main Methods:
- In vitro assessment of CAD27's effects on endothelial cell tube formation, migration, and aortic ring sprouting.
- In vivo evaluation of CAD27's impact on laser-induced CNV in rats via intravitreal injection and topical application.
- Assessment of retinal function using electroretinography.
Main Results:
- CAD27 significantly inhibited in vitro angiogenic activities.
- Intravitreal injection of CAD27 reduced CNV lesions by up to 22.4%.
- Topical application of CAD27 also reduced CNV lesions by up to 32.5%, with no adverse effects on retinal function.
Conclusions:
- CAD27 demonstrates potent anti-angiogenic properties and effectively reduces CNV in a preclinical model.
- CAD27 represents a promising therapeutic candidate for treating CNV in conditions like neovascular age-related macular degeneration.
Related Concept Videos
Peptide Bonds
Feedback Inhibition
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Membrane Domains
Protein Domains
The membrane comprises a group of distinct proteins responsible for carrying out a cell's specific function. For example, the plasma membrane of the human sperm, or a single germ cell, contains a unique set of proteins in the...
Three Developmental Domains
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
Three-Domain System of Life

